Logo image of MUX

MCEWEN MINING INC (MUX) Stock Fundamental Analysis

NYSE:MUX - New York Stock Exchange, Inc. - US58039P3055 - Common Stock - Currency: USD

7.14  -0.49 (-6.42%)

After market: 7.25 +0.11 (+1.54%)

Fundamental Rating

3

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 151 industry peers in the Metals & Mining industry. MUX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, MUX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MUX had negative earnings in the past year.
MUX had a positive operating cash flow in the past year.
In the past 5 years MUX reported 4 times negative net income.
In the past 5 years MUX always reported negative operating cash flow.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

With an excellent Return On Assets value of 15.42%, MUX belongs to the best of the industry, outperforming 95.10% of the companies in the same industry.
With an excellent Return On Equity value of 20.51%, MUX belongs to the best of the industry, outperforming 93.71% of the companies in the same industry.
Industry RankSector Rank
ROA 15.42%
ROE 20.51%
ROIC N/A
ROA(3y)-5.91%
ROA(5y)-11.53%
ROE(3y)-9.74%
ROE(5y)-16.57%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

1.3 Margins

Looking at the Profit Margin, with a value of 51.59%, MUX belongs to the top of the industry, outperforming 99.30% of the companies in the same industry.
MUX has a Gross Margin (22.15%) which is in line with its industry peers.
MUX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 51.59%
GM 22.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-15.64%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MUX has more shares outstanding
Compared to 5 years ago, MUX has more shares outstanding
MUX has a better debt/assets ratio than last year.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.96, we must say that MUX is in the distress zone and has some risk of bankruptcy.
MUX has a Altman-Z score of -0.96. This is amonst the worse of the industry: MUX underperforms 88.11% of its industry peers.
MUX has a debt to FCF ratio of 4.63. This is a neutral value as MUX would need 4.63 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.63, MUX is doing good in the industry, outperforming 68.53% of the companies in the same industry.
MUX has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.06, MUX is doing good in the industry, outperforming 65.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 4.63
Altman-Z -0.96
ROIC/WACCN/A
WACC9.3%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

MUX has a Current Ratio of 1.17. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.17, MUX is not doing good in the industry: 82.52% of the companies in the same industry are doing better.
MUX has a Quick Ratio of 1.17. This is a bad value and indicates that MUX is not financially healthy enough and could expect problems in meeting its short term obligations.
MUX's Quick ratio of 0.74 is on the low side compared to the rest of the industry. MUX is outperformed by 83.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.74
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.23% over the past year.
MUX shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.02%.
Measured over the past years, MUX shows a small growth in Revenue. The Revenue has been growing by 5.33% on average per year.
EPS 1Y (TTM)65.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.74%
Revenue 1Y (TTM)47.02%
Revenue growth 3Y16.62%
Revenue growth 5Y5.33%
Sales Q2Q%36.05%

3.2 Future

The Earnings Per Share is expected to grow by 26.73% on average over the next years. This is a very strong growth
MUX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.73% yearly.
EPS Next Y68.6%
EPS Next 2Y37.96%
EPS Next 3Y26.73%
EPS Next 5YN/A
Revenue Next Year28.44%
Revenue Next 2Y22.77%
Revenue Next 3Y10.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2 -3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MUX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MUX.
66.43% of the companies in the same industry are more expensive than MUX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 43.7
EV/EBITDA 14.07
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as MUX's earnings are expected to grow with 26.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.96%
EPS Next 3Y26.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MUX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MCEWEN MINING INC

NYSE:MUX (2/21/2025, 8:04:00 PM)

After market: 7.25 +0.11 (+1.54%)

7.14

-0.49 (-6.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners30.74%
Inst Owner Change1.17%
Ins Owners0.47%
Ins Owner Change0.09%
Market Cap377.85M
Analysts80
Price Target20.12 (181.79%)
Short Float %2.12%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.14%
Min EPS beat(2)-53.72%
Max EPS beat(2)64%
EPS beat(4)2
Avg EPS beat(4)-30.31%
Min EPS beat(4)-160.81%
Max EPS beat(4)64%
EPS beat(8)4
Avg EPS beat(8)-84.43%
EPS beat(12)5
Avg EPS beat(12)-98.78%
EPS beat(16)6
Avg EPS beat(16)-136.75%
Revenue beat(2)2
Avg Revenue beat(2)6.76%
Min Revenue beat(2)6.45%
Max Revenue beat(2)7.08%
Revenue beat(4)4
Avg Revenue beat(4)6.43%
Min Revenue beat(4)2.56%
Max Revenue beat(4)9.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)-4.78%
Revenue beat(16)6
Avg Revenue beat(16)-4.12%
PT rev (1m)0%
PT rev (3m)4.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.93%
EPS NY rev (3m)-4.63%
Revenue NQ rev (1m)-6.68%
Revenue NQ rev (3m)-16.59%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-13.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF 43.7
P/OCF 8.03
P/B 0.75
P/tB 0.75
EV/EBITDA 14.07
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)0.16
FCFY2.29%
OCF(TTM)0.89
OCFY12.46%
SpS3.77
BVpS9.49
TBVpS9.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.42%
ROE 20.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 51.59%
GM 22.15%
FCFM 4.33%
ROA(3y)-5.91%
ROA(5y)-11.53%
ROE(3y)-9.74%
ROE(5y)-16.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-15.64%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 4.63
Debt/EBITDA 1.06
Cap/Depr 127.74%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 160.57%
Profit Quality 8.4%
Current Ratio 1.17
Quick Ratio 0.74
Altman-Z -0.96
F-Score6
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)152.97%
Cap/Depr(5y)126.63%
Cap/Sales(3y)27.91%
Cap/Sales(5y)24.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.74%
EPS Next Y68.6%
EPS Next 2Y37.96%
EPS Next 3Y26.73%
EPS Next 5YN/A
Revenue 1Y (TTM)47.02%
Revenue growth 3Y16.62%
Revenue growth 5Y5.33%
Sales Q2Q%36.05%
Revenue Next Year28.44%
Revenue Next 2Y22.77%
Revenue Next 3Y10.73%
Revenue Next 5YN/A
EBIT growth 1Y99.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year106.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y109.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.82%
OCF growth 3YN/A
OCF growth 5YN/A